1 La demande de certificat doit être déposée:
2 Si ces délais ne sont pas respectés, l’IPI déclare la demande irrecevable.
265 Nouvelle teneur selon l’annexe ch. 2 de la LF du 18 mars 2016, en vigueur depuis le 1er janv. 2019 (RO 2017 2745, 2018 3575; FF 2013 1).
1 The certificate lapses where:
2 If all authorisations are suspended, the certificate is also suspended. Suspension does not interrupt the term of the certificate.270
3 The Swiss Agency for Therapeutic Products shall notify the IPI of any withdrawal or suspension of the authorisations.271
268 Amended by Annex No 2 of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).
270 Amended by Annex No 2 of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).
271 Amended by Annex No 2 of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).
Ceci n’est pas une publication officielle. Seule la publication opérée par la Chancellerie fédérale fait foi. Ordonnance sur les publications officielles, OPubl.
This document is not an official publication. Only the publication of the Federal Chancellery is legally binding.